Follow
Esther Drees
Esther Drees
Unknown affiliation
Verified email at drees.nl
Title
Cited by
Cited by
Year
Methodological guidelines to study extracellular vesicles
FAW Coumans, AR Brisson, EI Buzas, F Dignat-George, EEE Drees, ...
Circulation research 120 (10), 1632-1648, 2017
9532017
Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer
RJA Nilsson, N Karachaliou, J Berenguer, A Gimenez-Capitan, ...
Oncotarget 7 (1), 1066, 2016
2012016
Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients
MAJ van Eijndhoven, JM Zijlstra, NJ Groenewegen, EEE Drees, ...
JCI insight 1 (19), 2016
1622016
Detection and localization of early-and late-stage cancers using platelet RNA
S GJG, M Arkani, E Post, M Antunes-Ferreira, S D’Ambrosi, DCL Vessies, ...
Cancer Cell 40 (9), 999-1009. e6, 2022
382022
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin’s lymphoma and facilitates ultrasensitive residual disease detection
S Sobesky, L Mammadova, M Cirillo, EEE Drees, J Mattlener, H Dörr, ...
Med 2 (10), 1171-1193. e11, 2021
332021
The impact of semiautomatic segmentation methods on metabolic tumor volume, intensity, and dissemination radiomics in 18F-FDG PET scans of patients with classical Hodgkin lymphoma
J Driessen, GJC Zwezerijnen, H Schöder, EEE Drees, MJ Kersten, ...
Journal of Nuclear Medicine 63 (9), 1424-1430, 2022
252022
Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma
EEE Drees, MGM Roemer, NJ Groenewegen, J Perez‐Boza, ...
Journal of extracellular vesicles 10 (9), e12121, 2021
242021
Circulating miRNAs as biomarkers in aggressive B cell lymphomas
EEE Drees, DM Pegtel
Trends in cancer 6 (11), 910-923, 2020
232020
PCR-free shallow whole genome sequencing for chromosomal copy number detection from plasma of cancer patients is an efficient alternative to the conventional PCR-based approach
JJ Beagan, EEE Drees, P Stathi, PP Eijk, L Meulenbroeks, F Kessler, ...
The Journal of Molecular Diagnostics 23 (11), 1553-1563, 2021
92021
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP
J Driessen, MJ Kersten, L Visser, A van den Berg, SH Tonino, JM Zijlstra, ...
Leukemia 36 (12), 2853-2862, 2022
72022
Exhaustive circulating tumor DNA sequencing reveals the genomic landscape of Hodgkin lymphoma and facilitates ultrasensitive detection of minimal residual disease
S Sobesky, L Mammadova, M Cirillo, E Drees, J Mattlener, H Dörr, ...
medRxiv, 2021.03. 16.21253679, 2021
72021
Unbiased and UMI-informed sequencing of cell-free miRNAs at single-nucleotide resolution
MAJ van Eijndhoven, E Aparicio-Puerta, C Gómez-Martín, JM Medina, ...
bioRxiv, 2021.05. 04.442244, 2021
32021
Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
EEE Drees, J Driessen, GJC Zwezerijnen, SAWM Verkuijlen, JJ Eertink, ...
EJHaem 3 (3), 908-912, 2022
22022
EML4-ALK rearrangement in blood platelets and outcome to crizotinib in non-small-cell lung cancer patients.
N Karachaliou, RJA Nilsson, J Berenguer, A Gimenez Capitan, ...
Journal of Clinical Oncology 33 (15_suppl), 8082-8082, 2015
22015
Liquid Biopsy Strategies in Lymphoid Malignancies
EEE Drees
2024
Full-length tRNAs lacking a functional CCA tail are selectively sorted into the lumen of extracellular vesicles
C Scheepbouwer, E Aparicio-Puerta, C Gómez-Martin, ...
bioRxiv, 2024.05. 12.593148, 2024
2024
Development of a Quality Management System-controlled plasma EV-miRNA assay for monitoring on-treatment disease activity in patients with classic Hodgkin Lymphoma
EEE Drees, NJ Groenewegen, S Verkuijlen, MAJ van Eijndhoven, ...
VU Research Portal, 107, 2023
2023
Single-nucleotide resolution sequencing of vesicle-associated miRNAs (IsoSeek) for treatment response detection in Multiple Myeloma
EEE Drees, MAJ van Eijndhoven, C Gómez-Martín, E Aparicio-Puerta, ...
VU Research Portal, 131, 2023
2023
Pre-analytical considerations for multicenter extracellular vesicle-associated miRNA biomarker studies in Diffuse Large B-cell Lymphoma
EEE Drees, S Wang, C Gómez-Martín, MAJ van Eijndhoven, S Verkuijlen, ...
VU Research Portal, 177, 2023
2023
Harnessing Cell-Free DNA Biological Features for Early Treatment Response Prediction in High Grade B-Cell Lymphoma
Y van Der Pol, S Wang, N Moldovan, AV de Jonge, EEE Drees, ...
Blood 140 (Supplement 1), 3529-3531, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20